Found: 58
Select item for more details and to access through your institution.
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 4, p. 514, doi. 10.1002/phar.2242
- By:
- Publication type:
- Article
Household transmission of SARS-CoV-2 infection in the Paris/Ile-de-France area.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 3, p. 445, doi. 10.1007/s10096-021-04345-9
- By:
- Publication type:
- Article
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 583, doi. 10.3390/jpm13040583
- By:
- Publication type:
- Article
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 1974, doi. 10.1093/jac/dkae194
- By:
- Publication type:
- Article
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1673, doi. 10.1093/jac/dkae164
- By:
- Publication type:
- Article
Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2021, v. 76, n. 11, p. 3070, doi. 10.1093/jac/dkab295
- By:
- Publication type:
- Article
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
- Published in:
- 2020
- By:
- Publication type:
- letter
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. 462, doi. 10.1093/jac/dky443
- By:
- Publication type:
- Article
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 6, p. 1015, doi. 10.3390/cells11061015
- By:
- Publication type:
- Article
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 546, doi. 10.3390/v15020546
- By:
- Publication type:
- Article
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 226, doi. 10.3390/v14020226
- By:
- Publication type:
- Article
Expression and Activity of Cyclin-Dependent Kinases and Glycogen Synthase Kinase-3 during NT2 Neuronal Differentiation.
- Published in:
- NeuroSignals (Karger AG), 2004, v. 13, n. 3, p. 134, doi. 10.1159/000076567
- By:
- Publication type:
- Article
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Virological failure of patients on maraviroc-based antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1858, doi. 10.1093/jac/dkv026
- By:
- Publication type:
- Article
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 6, p. 1648
- By:
- Publication type:
- Article
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 3, p. 753, doi. 10.1093/jac/dkt428
- By:
- Publication type:
- Article
Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1243, doi. 10.1093/jac/dkt018
- By:
- Publication type:
- Article
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 727
- By:
- Publication type:
- Article
Pitfalls of HIV genotypic tropism testing after treatment interruption.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 188, doi. 10.1093/jac/dks362
- By:
- Publication type:
- Article
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2487
- By:
- Publication type:
- Article
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2323, doi. 10.1093/jac/dks219
- By:
- Publication type:
- Article
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 1, p. 250, doi. 10.1093/jac/dkr435
- By:
- Publication type:
- Article
Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 4, p. 709, doi. 10.1093/jac/dkq544
- By:
- Publication type:
- Article
Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 4, p. 749, doi. 10.1093/jac/dkq029
- By:
- Publication type:
- Article
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 4, p. 795, doi. 10.1093/jac/dkp014
- By:
- Publication type:
- Article
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 797
- By:
- Publication type:
- Article
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 9, p. 2781, doi. 10.1111/ene.15925
- By:
- Publication type:
- Article
Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1093, doi. 10.1093/cid/ciab580
- By:
- Publication type:
- Article
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 4, p. 707, doi. 10.1093/cid/ciab492
- By:
- Publication type:
- Article
Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1341, doi. 10.1093/infdis/jiad523
- By:
- Publication type:
- Article
Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0127816
- By:
- Publication type:
- Article
A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naïve Patients Starting a First-Line HAART.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0105853
- By:
- Publication type:
- Article
Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI --ANRS136 Trial over 96 Weeks.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041390
- By:
- Publication type:
- Article